Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic updates AneuRx system

This article was originally published in The Gray Sheet

Executive Summary

A newer version of Medtronic's AneuRx AAAdvantage abdominal aortic aneurysm (AAA) stent graft with the Xcelerant delivery system wins FDA approval. Updates to the new system include improved radiopaque markers and stent contouring. Roughly 1.2 mil. people in the United States have AAA, though only 15% are ever diagnosed, according to Medtronic. The AneuRx system was originally launched in the U.S. in 1996 (1"The Gray Sheet" Nov. 28, 2005, p. 9)...
Advertisement

Related Content

Endovascular AAA Repair Requires Reintervention More Often Than Surgery
Endovascular AAA Repair Requires Reintervention More Often Than Surgery
Advertisement
UsernamePublicRestriction

Register

MT023394

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel